SYNA Heads Into Earnings With a Deal Overhang Shaping Every Signal
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Synaptics Incorporated reports fiscal Q1 2027 results on November 5 with the stock trading just below the agreed $123 per share all-cash takeover price from ON Semiconductor, a deal structure that now colours almost every positioning signal heading into the print.
The borrow market is notably relaxed, which makes sense given the deal context. Short interest has been easing, down nearly 8% on the week to 6.6% of the float, with availability at 890%, meaning there are roughly nine shares available to lend for every one currently borrowed. Cost to borrow has dropped 19% on the week to just 0.42%. The ORTEX short score has also drifted lower, from 46.4 ten days ago to 44.5, moving away from the bearish half of the range. Options positioning is mildly defensive at a put/call ratio of 1.25, above its 20-day average of 1.10, though well within one standard deviation of that mean. The stock has gained 17% over the past month to $117.86, a rally that makes sense as shares have converged toward the $123 deal price from below.
The bull and bear debate here is less about quarterly momentum and more about the transaction itself. The bull case rests on certainty: a fixed $123 per share in cash, representing about 4.4x forward revenue, compares favourably to comparable semiconductor deals. The Q4 results showed solid operating traction, revenue of $308 million, non-GAAP gross margin of 54.5% and growing design wins in Physical AI and robotics. Bears point to the revised deal value being cut from roughly $7 billion to roughly $5.7 billion as evidence of weaker transaction economics, while FY26 non-GAAP EPS of $4.58 came in well short of the $5.61 consensus. Wells Fargo downgraded to Equal-Weight and trimmed its target to $123 in early October, essentially treating the deal price as the ceiling. With the stock at $117.86 and the analyst consensus mean at $131, some targets still sit above the deal price, a tension that reflects stale pre-deal estimates rather than a genuine fundamental bullish view.
Institutional ownership is also worth noting. Ameriprise (via Columbia Management) holds roughly 19.5% of the class as last disclosed, and BlackRock holds 12.5%. No Schedule 13D activist is on the register. The passive nature of the register, combined with the pending acquisition, removes the kind of activist pressure that might otherwise push for a higher bid. ORTEX forecasts an 84% probability that SYNA is deleted from the Russell 2000 and Russell 3000 in June 2027 upon deal close, with estimated trade-day volume at 9.1 times normal. Across 351 similar prior index deletions tied to acquisitions, the median move from announcement to effective date was negative 4.3%, though 80% moved in the expected direction.
Thursday's print is therefore less a traditional quarterly test and more a checkpoint on deal certainty: any guidance commentary, regulatory update or hint that the onsemi transaction is on or off schedule will carry more weight than the revenue or margin line itself.
Stocks in this article
See the live data behind this article on ORTEX.
Open SYNA on ORTEX →How this article was generated
- Generated
- 2 Nov 2026, 04:30
- Data as of
- 2 Nov 2026, 04:05
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.